Benzinga Research

Get Benzinga Pro
Data & APIs
Events
Premarket
Boost
Advertise

Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto

Free Benzinga Pro Trial

Calendars

Analyst Ratings Calendar

Conference Call Calendar

Dividend Calendar

Earnings Calendar

Economic Calendar

Guidance Calendar

Stock Split Calendar

Trade Ideas

Free Stock Reports

Trade Idea Feed

Analyst Ratings

Unusual Options Activity

Free Newsletter

Government Trades

Perfect Stock Portfolio

Easy Income Portfolio

Short Interest

Largest Increase

Largest Decrease

Calculators

Margin Calculator

Forex Profit Calculator

100x Options Profit Calculator

Comments

Loading...

Pfizer

PFENYSE

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Perks Buy Compare Brokers

$26.30

-0.19-0.72%

At close: -

$26.37

0.070.27%

After Hours: Jan 17, 7:58 PM EDT

The dividend Ex-Date is in 4 days

Q4 2024 Earnings in 15 days from now on Tue Feb 4th, before the market open

Pfizer (PFE) Forecast

News

Earnings Pfizer (PFE) Options Guidance Dividends Analyst Ratings Insider Trades Government Trades Short Interest

Latest news for Pfizer (NYSE:PFE) Stock

Pfizer Stock (NYSE: PFE)

Categories: All

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

All News

General

Contracts

Dividends

Events

FDA

M&A

Offerings

Stock Split

Media

Buybacks

Insider Trades

Earnings

Guidance

Analyst Ratings

Trading Ideas

Friday, January 17, 2025

Popular Ozempic, Wegovy Selected For Next Round Of Medicare Drug Price Negotiations
Vandana Singh
'Ozempic Is In The Next Round Of Medicare Dru...
Benzinga Newsdesk
Qorvo Soars 7% After Hours As Activist Investor Starboard Reportedly Takes Stake In Semiconductor Company
Kaustubh Bagalkote

Tuesday, January 14, 2025

Pfizer Eyes $20 Billion Revenue From Acquisitions Amid Patent Cliff Challenges
Vandana Singh
Clinical Research Firm ICON Faces Headwinds From Top Customers And Biotech Recovery Uncertainty
Vandana Singh
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Pfizer To Sell 700M Ordinary Shares In Haleon...
Benzinga Newsdesk

Monday, January 13, 2025

Pfizer CEO Albert Bourla Says "Looking At Eve...
Benzinga Newsdesk
A Closer Look at Pfizer's Options Market Dynamics
Benzinga Insights

Friday, January 10, 2025

BioNTech Positioned For Solid Growth Amid Oncology Transition: Analyst
Vandana Singh
Pfizer Reveals Encouraging Data From Pivotal Bladder Cancer Trial
Vandana Singh
Pfizer Is 'Too Low To Sell,' Jim Cramer Says: Recommends Nvidia For Robotics Exposure
Avi Kapoor
Pfizer Says Its Sasanlimab In Combination Wit...
Benzinga Newsdesk

Thursday, January 09, 2025

Obesity Treatments, M&A Activity To Take Center Stage During Upcoming JPM Healthcare Conference
Vandana Singh

Wednesday, January 08, 2025

Bird Flu Sparks Vaccine Stock Surge: ETFs To Watch As H5N1 Outbreak Intensifies
Chandrima Sanyal
Spotlight on Pfizer: Analyzing the Surge in Options Activity
Benzinga Insights
UBS Maintains Neutral on Pfizer, Lowers Price...
Benzinga Newsdesk
Pfizer And GSK's RSV Vaccines Safety Labels Updated, FDA Adds Warning For Rare Neurological Disorder
Vandana Singh

Tuesday, January 07, 2025

'Pfizer executives descend on Donald Trump's ...
Benzinga Newsdesk
PostEra Expands AI Drug Discovery Collaborati...
Benzinga Newsdesk

Monday, January 06, 2025

CVS Health's Aetna Files Lawsuit Against Drugmakers For Alleged Inflated Generic Drug Prices
Vandana Singh
Pfizer Antiviral Paxlovid's Extended Use Shows Mixed Results for Long COVID Relief: Study
Vandana Singh

Thursday, January 02, 2025

Atavistik Bio Has Entered Into A Research Col...
Benzinga Newsdesk

Wednesday, January 01, 2025

How Is The Market Feeling About Pfizer?
Benzinga Insights

Tuesday, December 31, 2024

Dow Dips Over 100 Points; Cocrystal Pharma Shares Slide
Avi Kapoor
Crude Oil Rises 1%; Sangamo Therapeutics Shares Plummet
Avi Kapoor
US Stocks Open Higher; House Prices Increase In October
Avi Kapoor
Sangamo Therapeutics Stock Plunges As Pfizer Terminates Hemophilia Gene Therapy Pact
Vandana Singh

Monday, December 30, 2024

Sangamo Therapeutics Reveals Pfizer's Decisio...
Benzinga Newsdesk
Pfizer's Options: A Look at What the Big Money is Thinking
Benzinga Insights

Friday, December 27, 2024

BioNTech Entered Settlement Agreement With NI...
Benzinga Newsdesk

Thursday, December 26, 2024

10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights

Tuesday, December 24, 2024

Court Rules Enanta Patent Invalid in Pfizer P...
Benzinga Newsdesk

Monday, December 23, 2024

Schwab US Dividend Equity ETF Reverses In December: What's Going On?
Erica Kollmann
This Is What Whales Are Betting On Pfizer
Benzinga Insights
Pfizer's Progress on C. diff Vaccine and Pneumococcal Shot Wins Analyst Conviction
Anusuya Lahiri

Friday, December 20, 2024

FDA Grants Accelerated Approval To Encorafeni...
Benzinga Newsdesk

Thursday, December 19, 2024

Your Healthcare Costs are Soaring! US Spending Reached $5 Trillion In 2023 with Major Increase in Obesity and Diabetes Drugs, Hospital Services
Vandana Singh

Wednesday, December 18, 2024

U.S. Supreme Court Agrees To Hear South Carol...
Benzinga Newsdesk
Truist Securities Maintains Buy on Pfizer, Lo...
Benzinga Newsdesk

Tuesday, December 17, 2024

What's Going On With CVS Health, UnitedHealth And Cigna Group Shares?
Adam Eckert
Benzinga Market Summary: S&P Falls, Pfizer Ri...
Benzinga Newsdesk
Stock Of The Day: Is Pfizer About To Break Out? Expect A New Uptrend If Resistance Breaks
Mark Putrino
Stocks Slip As Strong November Retail Sales Raise Concerns Over 2025 Fed Rate Cuts
Piero Cingari
Pfizer CFO Does Not Expect Large Deals In 202...
Benzinga Newsdesk
Pfizer Does Not Anticipate Material Changes To US Vaccine Policy From The Incoming Administration In 2025
Vandana Singh
Pfizer Expects No Material US Policy Changes ...
Benzinga Newsdesk
Pfizer shares are trading higher after the co...
Benzinga Newsdesk
Pfizer Reaffirms FY24 Outlook For Revenue Of ...
Benzinga Newsdesk
Pfizer Says First Phase Of Manufacturing Opti...
Benzinga Newsdesk

Create a Watchlist

FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.

People Also Watch

Popular Channels

PreMarket Playbook
Press Releases
Analyst Ratings
News
Options
ETFs

Tools & Features

Real Time Feed
Public RSS Feeds
Submit News Tips
Blog
Embeddable Finance Widgets & Tools
Benzinga Catalyst

Partners & Contributors

Affiliate Program
Contributor Portal
Licensing & Syndication
Sponsored Content
Advertise With Us
Lead Generation & SEO

About Benzinga

About Us
Careers
In The News
Events
Contact Us

Terms & Conditions
Do Not Sell My Personal Data/Privacy Policy
Disclaimer
Service Status
Sitemap

© 2025 Benzinga | All Rights Reserved